You can find the annual or quarterly income statement of Guardian Pharmacy Services Inc here for insights into the performance and operational efficiency of Guardian Pharmacy Services Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q2
FY2023Q1
FY2022Q2
FY2022Q1
Total revenue
2.16%351.77M
2.21%336.60M
17.44%397.62M
20.05%377.43M
35.86%344.33M
19.57%329.31M
--338.57M
--314.39M
0.00%253.44M
10.63%275.41M
13.10%253.44M
17.96%248.95M
--224.08M
--211.05M
Revenue
2.16%351.77M
2.21%336.60M
17.44%397.62M
20.05%377.43M
35.86%344.33M
19.57%329.31M
--338.57M
--314.39M
0.00%253.44M
10.63%275.41M
13.10%253.44M
17.96%248.95M
--224.08M
--211.05M
Cost of revenue
-1.62%271.72M
-1.76%260.29M
14.97%312.11M
19.40%302.71M
35.97%276.19M
20.27%264.96M
--271.46M
--253.51M
0.00%203.12M
11.42%220.31M
14.27%203.12M
16.96%197.73M
--177.75M
--169.06M
Operating expenses
-0.19%331.12M
0.83%318.92M
14.00%366.85M
-13.83%361.07M
45.41%331.75M
18.25%316.30M
--321.81M
--419.01M
0.00%228.14M
10.30%267.48M
1.07%228.14M
27.94%242.49M
--225.74M
--189.54M
Depreciation, depletion, and amortization
5.81%5.81M
13.46%5.98M
11.41%5.74M
1.76%5.84M
-38.20%5.49M
10.86%5.27M
--5.15M
--5.74M
100.77%8.88M
6.57%4.75M
10.02%4.42M
9.51%4.46M
--4.02M
--4.07M
Operating profit
64.10%20.64M
35.91%17.68M
83.60%30.76M
115.63%16.35M
-50.27%12.58M
63.94%13.01M
--16.75M
---104.61M
0.00%25.30M
22.86%7.93M
1624.71%25.30M
-69.98%6.46M
---1.66M
--21.51M
Net non-operating interest income (expenses)
Non-operating interest expense
-10.47%154.00K
-9.41%154.00K
-61.28%163.00K
-84.41%160.00K
-75.50%172.00K
-77.78%170.00K
--421.00K
--1.03M
0.00%702.00K
8.97%765.00K
66.75%702.00K
72.48%702.00K
--421.00K
--407.00K
Special income (expenses)
95.16%-121.00K
29.62%-770.00K
----
----
---2.50M
---1.09M
----
----
----
----
----
----
----
----
Other non-operating income (expenses)
252.00%9.42M
12.97%1.54M
542.48%500.00K
21950.00%437.00K
1872.85%2.68M
1969.86%1.36M
---113.00K
---2.00K
0.00%-151.00K
-78.05%-73.00K
-88.75%-151.00K
48.10%-41.00K
---80.00K
---79.00K
Income before tax
136.69%29.79M
39.58%18.29M
91.72%31.10M
115.74%16.63M
-48.50%12.59M
84.72%13.11M
--16.22M
---105.64M
0.00%24.44M
24.17%7.09M
1231.57%24.44M
-72.82%5.71M
---2.16M
--21.02M
Income tax
104.02%7.67M
23.90%4.75M
124.52%9.83M
3898.86%7.04M
--3.76M
--3.83M
--4.38M
--176.00K
----
--0.00
----
----
----
----
Income after tax
150.61%22.12M
46.06%13.54M
79.59%21.27M
109.07%9.59M
-63.89%8.83M
30.70%9.27M
--11.84M
---105.82M
0.00%24.44M
24.17%7.09M
1231.57%24.44M
-72.82%5.71M
---2.16M
--21.02M
Net income from continuous operations
150.61%22.12M
46.06%13.54M
79.59%21.27M
109.07%9.59M
-63.89%8.83M
30.70%9.27M
--11.84M
---105.82M
0.00%24.44M
24.17%7.09M
1231.57%24.44M
-72.82%5.71M
---2.16M
--21.02M
Net Income attributable to non-controlling interests
222.66%249.00K
242.29%249.00K
435.29%342.00K
-103.30%-225.00K
-106.83%-203.00K
-104.06%-175.00K
---102.00K
--6.82M
0.00%2.97M
7.46%4.31M
-21.38%2.97M
31.17%4.01M
--3.78M
--3.06M
Net income attributable to controlling interests
142.21%21.87M
40.72%13.29M
75.19%20.92M
108.05%9.82M
-57.94%9.03M
--9.45M
--11.94M
---121.99M
0.00%21.47M
-100.00%0.00
461.45%21.47M
-90.52%1.70M
---5.94M
--17.97M
Net income attributable to common shareholders
142.21%21.87M
40.72%13.29M
75.19%20.92M
108.05%9.82M
-57.94%9.03M
--9.45M
--11.94M
---121.99M
0.00%21.47M
-100.00%0.00
461.45%21.47M
-90.52%1.70M
---5.94M
--17.97M
Basic earnings per share
137.32%0.35
37.88%0.21
78.68%0.33
107.92%0.16
-57.91%0.15
--0.15
--0.18
---2.00
0.00%0.35
-100.00%0.00
461.45%0.35
-90.52%0.03
---0.10
--0.29
Diluted earnings per share
139.82%0.34
39.00%0.21
68.96%0.31
107.92%0.16
-58.68%0.14
--0.15
--0.18
---2.00
0.00%0.35
-100.00%0.00
461.45%0.35
-90.52%0.03
---0.10
--0.29
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
FAQs
How do I read Guardian Pharmacy Services Inc's income statement on TradingKey?
Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.
What is the difference between quarterly and annual income statements?
A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.
What does YOY mean on the income statement page?
YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.
Which income statement metrics matter most when analyzing GRDN stock?
Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.
What was Guardian Pharmacy Services Inc's revenue at year end?
Guardian Pharmacy Services Inc reported 1.45B in revenue for fiscal year 2025, up from 1.23B in the previous year.
How much revenue did Guardian Pharmacy Services Inc report in the most recent quarter?
Guardian Pharmacy Services Inc reported 351.77M in revenue for the most recent quarter, an increase of 2.16% year over year.
What was Guardian Pharmacy Services Inc's net income for the year?
Guardian Pharmacy Services Inc posted 49.22M in net income for fiscal year 2025.
How much net income did Guardian Pharmacy Services Inc post in the last quarter?
Guardian Pharmacy Services Inc reported 21.87M in net income for the latest quarter。
What was Guardian Pharmacy Services Inc's annual operating profit?
Guardian Pharmacy Services Inc's operating income was 72.70M for fiscal year 2025.
How is EPS related to the income statement?
EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.